Background: Incident Serum Albumins (SA) have been extensively studied as a prognostic indicator in community-dwelling and hospitalized older adults, but less is known about the association between SA and long-term outcomes among older patients admitted to a Recuperative Care and Rehabilitation Unit (RCRU).The study purpose was to examine the association between SA obtained at discharge from a RCRU and the risk of mortality over the subsequent 9.2 years.

Methods: This prospective cohort studyincluded383 older Veterans (mean age = 78.6±7.6 years, 98% male, and 87% white) who were discharged alive and in stable medical condition from a Department of Veterans Affairs Community Living Center RCRU with outpatient follow-up. At discharge, each subject completed a comprehensive assessment and was then monitored as an outpatient for up to 9.2 years. Associations between SA at RCRU discharge and mortality were identified utilizing Cox proportional hazards (PH) regression analyses adjusting for conditions known to confound this relationship. ;

Results: The mean (SD) discharge albumin was 3.3 g/dL (0.4). During the study, 255 subjects (67%) died. The risk of death for those with albumin 3.4 was 3.1 times higher at year 2 (HR=3.09 [95% CI, 2.14, 4.48], p<0.001), but by year 3 the risk of death between the two groups was no significant (HR=1.41 [95% CI, 0.97-2.05], p=0.074). Conclusions/Implications: Among older Veterans, SA obtained at discharge from a RCRU is significantly associated with the risk of mortality over the subsequent two years. Veterans with a low RCRU discharge SA may need more aggressive monitoring and care during this period of increased mortality risk.

Despite great advancement in food technology and manufacturing, epidemiological diseases that stemmed from food consumption are still a persistent threat to human health or even his life. Great awareness and understanding about food metabolism and excellence in quality of production have been achieved through the last decades

Magnesium gluconate is the best source of magnesium for the human body, which is required for the metabolic processes, normal functioning of nerves, cells, muscles, bones, heart, etc. The aim of this research was to investigate the impact of the Trivedi Effect® on Mg-gluconate on the structural properties and isotopic abundance ratio using LC-MS and NMR spectroscopy. Magnesium gluconate sample was divided into two parts – one part was control sample, and another part was received the Biofield Energy Healing Treatment by a famous Biofield Energy Healer, Mr. Mahendra Kumar Trivedi is known as treated sample. The LC-MS of both the samples revealed the presence of protonated magnesium gluconate mass [M+H]+ peak at m/z 415 (calcd for C12 H23 MgO14 +, 415.09) at the retention time of 1.68 minutes. However, the relative peak intensities of the Biofield Energy Treated sample were significantly altered compared with the control sample. The isotopic abundance ratio of PM+2 /PM (26Mg/24Mg or 18O/16O) was significantly increased by 58%, in the treated sample compared with the control sample. Briefly, 18O and 26Mg contributions from C12 H23 MgO14 + to m/z 417 in the Biofield Energy Treated magnesium gluconate was significantly increased compared with the control sample. The proton and carbon signals for OH, CH, CH2 and CO groups in the proton and carbon NMR spectra of the Biofield Energy Treated sample were almost similar compared to the control sample. The improvement in the isotopic abundance ratios of the treated magnesium gluconate might be due to the possible mediation of neutrinos via the Trivedi Effect®-Consciousness Energy Healing Treatment. The increased isotopic abundance ratio of the treated magnesium gluconate might improve strong atomic bond, increase the stability, and alter the rate of metabolic reactions in the body. Thus, the Biofield Energy Treated magnesium gluconate would be supportive to design the novel potent enzyme inhibitors using its kinetic isotope effects. Similarly, the Biofield Energy Treated magnesium gluconate could be valuable for designing better pharmaceutical and nutraceutical formulations, which might provide better therapeutic response against various diseases such as diabetes mellitus, aging, allergy, immunological disorders, inflammatory diseases, and other chronic infections.